TrialScientific reports2026

The effect of empagliflozin on inflammation and oxidative stress in patients undergoing percutaneous coronary intervention, a randomized controlled trial.

Susan Darroudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.